A Review of the Research Progress and Application of Skin Care Ointments in Chronic Eczema Treatment ...
Paratek will accelerate access for XHANCE beyond specialists to primary care providers maximizing the recent label expansion for CRS in a ...
Crohn's disease belongs to a group of conditions known as inflammatory bowel diseases (IBD). This chronic condition causes ...
Pharmaceuticals generated fourth quarter 2024 net FUROSCIX® revenue of $12.2 million, and full year 2024 revenue of $36.3 millionCash and cash ...
eVnExpress on MSN1d
Important considerations for breast reduction surgeryBreast reduction surgery offers several benefits but also involves potential risks. Understanding the surgical process and ...
Xeris Biopharma Holdings, Inc. (Nasdaq: XERS), a growth-oriented biopharmaceutical company committed to improving patient ...
Furoscix is a pH-neutral formulation of furosemide, a loop diuretic, designed for subcutaneous (SC) administration via a wearable, single-use, pre-programmed on-body infusor for outpatient ...
The patients having erythema lesions were examined and interviewed ... headache, night sweats, excessive fatigue and dry, hacking cough. As shown in Figure 2, the periods from onset of clinical ...
Furosemide injection was previously approved to treat congestion from fluid buildup in adults with chronic heart failure.
Your skin can signal hidden health issues, from diabetes to liver disease. Learn how to recognize early warning signs before conditions worsen.
GlobalData on MSN12d
FDA approves scPharmaceuticals’ Furoscix sNDA for oedema in CKDThe Furoscix 80 mg/10 ml subcutaneous injection is intended for oedema in adult CKD patients, including those with nephrotic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback